Back to Search Start Over

DICER1 syndrome: clarifying the diagnosis, clinical features and management implications of a pleiotropic tumour predisposition syndrome

Authors :
Ingrid Slade
Bruce Morland
Derek J. King
Charles A. Stiller
Kathryn Pritchard-Jones
Clare Turnbull
Lucy Side
Sucheta Vaidya
Anne Murray
Helen Davies
Katrina Prescott
Barry Pizer
Paul Ward
Heidi Traunecker
Rita Barfoot
Anand Saggar
Richard S. Houlston
Helen Jenkinson
Sandra Hanks
Michael R. Stratton
Gordan M. Vujanic
Andrew G. Nicholson
Julia C. Chisholm
Nazneen Rahman
P. Andrew Futreal
Martin Hewitt
Amos Burke
Fatemeh Abbaszadeh
Jenny Douglas
John R. Priest
Neil J. Sebire
Chiara Bacchelli
Source :
Journal of medical genetics. 48(4)
Publication Year :
2011

Abstract

BACKGROUND: Constitutional DICER1 mutations were recently reported to cause familial pleuropulmonary blastoma (PPB). AIM: To investigate the contribution and phenotypic spectrum of constitutional and somatic DICER1 mutations to cancer. METHODS AND RESULTS: The authors sequenced DICER1 in constitutional DNA from 823 unrelated patients with a variety of tumours and in 781 cancer cell lines. Constitutional DICER1 mutations were identified in 19 families including 11/14 with PPB, 2/3 with cystic nephroma, 4/7 with ovarian Sertoli-Leydig-type tumours, 1/243 with Wilms tumour (this patient also had a Sertoli-Leydig tumour), 1/1 with intraocular medulloepithelioma (this patient also had PPB), 1/86 with medulloblastoma/infratentorial primitive neuroectodermal tumour, and 1/172 with germ cell tumour. The inheritance was investigated in 17 families. DICER1 mutations were identified in 25 relatives: 17 were unaffected, one mother had ovarian Sertoli-Leydig tumour, one half-sibling had cystic nephroma, and six relatives had non-toxic thyroid cysts/goitre. Analysis of eight tumours from DICER1 mutation-positive patients showed universal retention of the wild-type allele. DICER1 truncating mutations were identified in 4/781 cancer cell lines; all were in microsatellite unstable lines and therefore unlikely to be driver mutations. CONCLUSION: Constitutional DICER1 haploinsufficiency predisposes to a broad range of tumours, making a substantial contribution to PPB, cystic nephroma and ovarian Sertoli-Leydig tumours, but a smaller contribution to other tumours. Most mutation carriers are unaffected, indicating that tumour risk is modest. The authors define the clinical contexts in which DICER1 mutation testing should be considered, the associated tumour risks, and the implications for at-risk individuals. They have termed this condition 'DICER1 syndrome'. ACCESSION NUMBERS: The cDNA Genbank accession number for the DICER1 sequence reported in this paper is NM_030621.2.

Details

ISSN :
14686244
Volume :
48
Issue :
4
Database :
OpenAIRE
Journal :
Journal of medical genetics
Accession number :
edsair.doi.dedup.....6ab8cab08e93f51dcda644e01a87095e